Reported Earlier, Moderna Initiates Phase 3 Study Of Investigational mRNA Pandemic Influenza Vaccine Candidate mRNA-1018 In US And UK

Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat